Among prolactinoma patients, clinical presentations are associated with either excessive autonomic production of prolactin by the lactotroph cells, leading to hyperprolactinemia, or mass effect caused by tumor size [18]. The gene discussed is PRL; the disease is hyperprolactinemia.